Tag Archives: cell therapy

EQT Private Equity gab die Übernahme von SPT Labtech von Battery Ventures für 650 Millionen GBP bekannt

(PRESSEMITTEILUNG) STOCKHOLM, 22-Jun-2022 — /EuropaWire/ — EQT AB, eine zweckorientierte globale Investmentgesellschaft, hat die Übernahme von SPT Labtech bekannt gegeben von Battery Ventures, einer globalen, technologieorientierten Investmentgesellschaft, für 650 Mio. GBP (~ 756 Mio. EUR). SPT Labtech ist ein britisches … Read the full press release

EQT Private Equity announced the acquisition of SPT Labtech from Battery Ventures for GBP 650 million

(PRESS RELEASE) STOCKHOLM, 22-Jun-2022 — /EuropaWire/ — EQT AB, a purpose-driven global investment organization, has announced the acquisition of SPT Labtech from Battery Ventures, a global, technology-focused investment firm, for GBP 650 million (~ EUR 756 million). SPT Labtech is … Read the full press release

Bayer to use Mammoth’s CRISPR systems for the development of vivo gene-editing therapies

Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s vision of unlocking the full potential of novel CRISPR systems / Mammoth to receive upfront payment of USD 40 million, and potential future milestone payments of more … Read the full press release

Kuehne+Nagel’s subsidiary QuickSTAT opens new control tower in Singapore for time-critical clinical trial logistics

(PRESS RELEASE) SINGAPORE, 22-Jul-2021 — /EuropaWire/ — Kuehne+Nagel, one of the world’s leading logistics companies, has announced that its subsidiary QuickSTAT has opened a new control tower and conditioning facility in Singapore. The investment is part of Kuehne+Nagel and QuickSTAT’s … Read the full press release